Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Tonix Pharmaceuticals Holding (TNXP) Other Non-Current Liabilities (2023)

Tonix Pharmaceuticals Holding (TNXP) has 1 years of Other Non-Current Liabilities data on record, last reported at $14.6 million in Q4 2023.

  • For Q4 2023, Other Non-Current Liabilities changed N/A year-over-year to $14.6 million; the TTM value through Dec 2023 reached $14.6 million, changed N/A, while the annual FY2023 figure was $14.6 million, N/A changed from the prior year.
  • Other Non-Current Liabilities reached $14.6 million in Q4 2023 per TNXP's latest filing.
  • Across five years, Other Non-Current Liabilities topped out at $14.6 million in Q4 2023 and bottomed at $14.6 million in Q4 2023.